Fig. 2: Glucosylceramide and sphingomyelin in PD patients with distinct types of GBA variants. | npj Parkinson's Disease

Fig. 2: Glucosylceramide and sphingomyelin in PD patients with distinct types of GBA variants.

From: Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI

Fig. 2

a Glucosylceramide fraction in patients with idiopathic PD and in GBA-PD patients carrying risk variants (RV), mild mutations, and severe mutations. b Sphingomyelin fraction in patients with idiopathic PD and in GBA-PD patients with risk variants (RV), mild mutations, and severe mutations. Unadjusted sphingolipid fractions in CSF of 271 PD patients are shown in box and jitter dot blots.

Back to article page